The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury.

Shakur, H; Andrews, P; Asser, T; Balica, L; Boeriu, C; Quintero, JD; Dewan, Y; Druwé, P; Fletcher, O; Frost, C; +10 more... Hartzenberg, B; Mantilla, JM; Murillo-Cabezas, F; Pachl, J; Ravi, RR; Rätsep, I; Sampaio, C; Singh, M; Svoboda, P; Roberts, I; (2009) The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury. Trials, 10. p. 109. ISSN 1745-6215 DOI: https://doi.org/10.1186/1745-6215-10-109

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/1745-6215-10-109

Abstract

Share

Download

Filename: The BRAIN TRIAL_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar